GlassScriptPhysician profile
Azhar I Chaudhry
NPI 1669491726
$2,169.77
in general payments reported to CMS, 2019-2025
19 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $154 · 2021: $19.48 · 2022: $325 · 2023: $352 · 2024: $252 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $336.98 | 2019-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $299.98 | 2019-2025 | Farxiga, Breztri |
| Acadia Pharmaceuticals INC | $249.94 | 2023 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $176.23 | 2019 | |
| Medtronic, INC. | $157.11 | 2024 | Hawkone |
| Painteq LLC | $150.27 | 2022-2023 | Painteq |
| Sanofi-Aventis U.S. LLC | $124.97 | 2022 | |
| Novo Nordisk INC | $114.90 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Urovant Sciences INC | $111.19 | 2022 | |
| Abbott Laboratories | $106.60 | 2023-2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $100.96 | 2019 | |
| Amgen INC. | $51.67 | 2019-2025 | Otezla, Repatha |
| Lilly USA, LLC | $38.63 | 2025 | Mounjaro |
| Intra-Sana Laboratories | $37.15 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Gilead Sciences, INC. | $26.98 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $24.71 | 2025 | Korlym |
| Amphastar Pharmaceuticals, INC. | $24.25 | 2025 | |
| Abiomed | $19.70 | 2025 | |
| Renalytix Ai, INC. | $17.55 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azhar Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.